Longevity ResearchLast updated: 2026-06-057 min
NAD+ UK: Research Reference 2026

NAD+ UK: Research Reference 2026

Hati Peptides
Research Use Only

This reference is strictly for laboratory and in vitro research purposes. Not for human or animal consumption. Not a medicine, food, cosmetic, or dietary supplement. Not approved by the MHRA.

Overview

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in all living cells. It is a dinucleotide composed of two nucleotides joined by their phosphate groups: one nucleotide contains an adenine base, and the other contains nicotinamide. NAD+ is central to metabolism, serving as an essential electron carrier in redox reactions and as a substrate for several classes of enzymes involved in cellular signalling and DNA repair.

The molecule exists in two forms: NAD+ (oxidised) and NADH (reduced). The NAD+/NADH ratio is a critical indicator of cellular metabolic state, with high NAD+ levels associated with active metabolism and high NADH levels associated with reduced metabolic activity. NAD+ levels decline with age, falling by approximately 50% between age 20 and age 60 in human tissues.

For UK research laboratories, NAD+ serves as a reference compound for studies examining cellular metabolism, redox biology, and the role of NAD+-dependent enzymes in ageing and metabolic regulation. The coenzyme is supplied in lyophilised form for maximum stability and is reconstituted immediately before use in assays.

Molecular Structure

NAD+ is a dinucleotide with the following structural characteristics:

  • Formula: C21H27N7O14P2
  • Molecular weight: 663.4 Da (oxidised form)
  • Structure: Adenine + ribose + pyrophosphate + nicotinamide + ribose
  • Redox centre: Nicotinamide ring (accepts/donates hydride ion, H−)
  • Charge: Net negative charge at physiological pH due to phosphate groups

The molecule consists of two nucleotides—adenosine monophosphate (AMP) and nicotinamide monophosphate (NMN)—joined by a pyrophosphate linkage. The nicotinamide moiety contains a positively charged pyridinium ring that is the site of redox chemistry. Upon reduction, NAD+ accepts a hydride ion (two electrons and one proton) at the C4 position of the nicotinamide ring, forming NADH.

Mechanism of Action

NAD+ operates through several distinct mechanisms in cellular and in vitro models:

Redox Metabolism

NAD+ serves as an electron carrier in metabolic reactions. In glycolysis, the citric acid cycle, and fatty acid oxidation, NAD+ accepts electrons from substrates, becoming NADH. The NADH then donates electrons to the electron transport chain, driving ATP synthesis. The NAD+/NADH ratio regulates metabolic flux and cellular energy status.

Sirtuin Activation

NAD+ is the essential substrate for sirtuins (SIRT1–SIRT7), a family of NAD+-dependent deacetylases. Sirtuins regulate gene expression, metabolic pathways, and cellular stress responses by removing acetyl groups from histones and other proteins. In cellular models, NAD+ availability directly determines sirtuin activity, linking metabolic state to epigenetic regulation.

PARP Activity

NAD+ is consumed by poly(ADP-ribose) polymerases (PARPs), enzymes that detect DNA damage and initiate repair. PARP1, the most abundant PARP, consumes NAD+ to synthesise poly(ADP-ribose) chains on target proteins, recruiting DNA repair machinery. In cellular studies, excessive DNA damage can deplete NAD+ through PARP overactivation.

CD38 and NAD+ Degradation

CD38 is a membrane-bound NADase that degrades NAD+ to cyclic ADP-ribose (cADPR) and nicotinamide. CD38 expression increases with age, contributing to NAD+ decline. In cellular models, CD38 inhibition preserves NAD+ levels and maintains sirtuin activity.

NAD+ Salvage Pathway

Cells regenerate NAD+ through the salvage pathway, converting nicotinamide to NMN via nicotinamide phosphoribosyltransferase (NAMPT), then to NAD+ via NMN adenylyltransferase (NMNAT). In cellular studies, NAMPT expression and activity determine the rate of NAD+ resynthesis.

Research Applications

NAD+ is employed across multiple research domains in UK laboratories:

Metabolic Research

In vitro studies examine NAD+ as a cofactor in glycolytic, citric acid cycle, and oxidative phosphorylation assays. Researchers use NAD+ to study metabolic flux, electron transport chain activity, and ATP production in cellular models. The NAD+/NADH ratio is measured as an indicator of metabolic state.

Ageing and Cellular Senescence

Cellular senescence models examine NAD+ decline as a marker of ageing. Researchers study the effects of NAD+ depletion on sirtuin activity, mitochondrial function, and DNA repair capacity. The relationship between NAD+ levels and cellular senescence markers (p16, p21, SA-β-gal) is quantified in ageing models.

DNA Repair and Genotoxic Stress

Cellular models of genotoxic stress examine NAD+ consumption by PARPs during DNA damage response. Researchers study whether NAD+ supplementation supports DNA repair capacity, reduces chromosomal aberrations, and maintains genomic stability in stressed cells.

Mitochondrial Function

NAD+ is essential for mitochondrial bioenergetics. In cellular models, NAD+ levels are correlated with mitochondrial membrane potential, ATP synthesis rate, and reactive oxygen species production. Researchers examine whether NAD+ availability supports mitochondrial biogenesis and function.

Sirtuin Pharmacology

NAD+ is used as a cofactor in sirtuin activity assays. Researchers compare NAD+ concentrations, sirtuin substrate specificity, and the effects of NAD+ modulators on deacetylase activity in cellular extracts.

Cellular and In Vitro Models

UK research laboratories employ several standard cellular models for NAD+ studies:

NAD+/NADH Ratio Assays

Cellular lysates are assayed for NAD+ and NADH content using enzymatic cycling assays or fluorescent probes. The NAD+/NADH ratio is calculated as a metabolic indicator. NAD+ is added to cell culture media or directly to lysates depending on the assay format.

Sirtuin Activity Assays

Cellular extracts or recombinant sirtuins are incubated with NAD+ and acetylated substrate peptides. Deacetylation is measured by fluorescence or luminescence. NAD+ concentration is varied to determine Km and Vmax parameters for different sirtuin isoforms.

PARP Activity Assays

Cellular extracts or recombinant PARP1 are incubated with NAD+ and DNA substrates. Poly(ADP-ribose) synthesis is measured by antibody detection or radioactive labelling. NAD+ consumption is quantified as a function of DNA damage signal.

Mitochondrial Respiration

Seahorse respirometry and isolated mitochondria assays measure oxygen consumption rate in response to NAD+ availability. NAD+ is added to media or mitochondrial suspensions to examine effects on Complex I activity and electron transport chain function.

Cellular NAD+ Depletion Models

Cells are treated with NAD+ depleting agents (FK866, a NAMPT inhibitor) to model age-related NAD+ decline. The effects of NAD+ supplementation on cellular function, gene expression, and stress resistance are examined.

Safety Profile in Preclinical Research

NAD+ safety profile is based on cellular and biochemical studies. As a natural coenzyme present in all cells, NAD+ has low inherent toxicity. In vitro studies have not identified cytotoxicity at physiological and supraphysiological concentrations.

In cellular models, excessive NAD+ supplementation may alter the NAD+/NADH ratio and metabolic flux, though cells regulate NAD+ uptake and utilisation through feedback mechanisms. The primary consideration is maintaining the oxidised/reduced ratio appropriate for the specific assay.

NAD+ is light-sensitive and degrades in solution over time. Freshly prepared solutions are recommended for cellular assays. The coenzyme is generally stable as a lyophilised powder under proper storage conditions.

Standard laboratory precautions apply: NAD+ is a research biochemical, not a medicine or dietary supplement. It is supplied for in vitro and laboratory research only.

Reconstitution and Handling

NAD+ is supplied as a lyophilised powder in research-grade vials. Standard laboratory preparation:

  • Reconstitution: Sterile water or phosphate-buffered saline (PBS) is recommended for laboratory preparations
  • Concentration: Typical stock concentrations range from 10–100 mM depending on assay requirements
  • Storage: Lyophilised powder at −20 °C, protected from light; reconstituted solution at 2–8 °C, use within 24 hours
  • Stability: NAD+ is unstable in solution; prepare fresh for each assay and avoid storage of reconstituted solutions
  • Solubility: Freely soluble in aqueous solutions; gentle vortexing may aid dissolution
  • Light sensitivity: Protect from light during storage and use; degradation products include NADH and nicotinamide
  • pH: Optimal stability at pH 7.0–8.0; avoid acidic or strongly alkaline conditions

The lyophilised powder is hygroscopic; store in a desiccated environment. Reconstituted solutions may turn yellow if contaminated with NADH; discard if colour change is observed. Use glass or high-quality polypropylene containers to minimise adsorption.

UK Research Status

NAD+ is not a controlled substance under the UK Misuse of Drugs Act 1971 and is not scheduled under the Psychoactive Substances Act 2016. It is classified as a research biochemical for laboratory use and is not licensed as a medicine by the MHRA.

For UK research laboratories, NAD+ is available as a research-grade reference material. Sourcing should include:

  • Certificate of Analysis confirming ≥99% purity (HPLC)
  • Mass spectrometry or NMR identity confirmation (molecular weight 663.4 Da)
  • Confirmation of oxidised form (NAD+), not reduced form (NADH)
  • Batch-specific testing documentation
  • Appropriate storage and shipping conditions (cold chain, protected from light)
  • Research-use-only labelling

Researchers should ensure compliance with institutional ethics approvals for animal studies, and adhere to standard laboratory safety protocols for biochemical handling.

Frequently Asked Questions

References

  1. [1] Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol 2014;24:464-471.
  2. [2] Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr 2008;28:115-130.
  3. [3] Yoshino J, Baur JA, Imai SI. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab 2018;27:513-528.
  4. [4] Camacho-Pereira J et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab 2016;23:1127-1139.
  5. [5] Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 2012;13:225-238.
Related Research Products

For laboratory and in vitro research use only. Not for human consumption. Not a medicine. Nothing in this article constitutes medical advice. UK researchers are responsible for compliance with the Human Medicines Regulations 2012 and Misuse of Drugs Regulations 2001 where applicable.

Research Updates

Get notified when new laboratory guides, research articles, and products are published. No spam — just research-focused updates.

Unsubscribe anytime. Your email is never shared.